Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update

Medicine & Life Sciences

• Amyloidosis, Hereditary, Transthyretin-Related 100%
• Genetic Profile 83%
• Amyloidosis 31%
• Late Onset Disorders 9%
• Asymptomatic Diseases 9%
• South America 8%
• Genes 8%
• Phenotype 8%
• Nerve Tissue 8%
• Mutation 7%
• North America 7%
• Peripheral Nerves 6%
• Amyloid 6%
• Age of Onset 6%
• Longitudinal Studies 5%
• Nervous System 5%
• Observational Studies 5%
• Genotype 5%
• Heart 4%